Rectal cancer stage III – Diagnostics – Overview of Information and Clinical Research

Diagnosing stage III rectal cancer requires careful testing to understand how far the disease has spread and determine the best path forward for treatment. The journey from noticing symptoms to receiving a diagnosis involves multiple steps, each providing crucial information that shapes your care plan.

Introduction: When to Seek Diagnostic Testing

Anyone experiencing persistent changes in their bowel habits should consider seeking medical evaluation. The symptoms that might prompt you to visit a doctor include rectal bleeding, which appears as blood in your stool or when you wipe. Some people notice their stool looks different than usual, perhaps appearing stringy or as thin as a pencil. Others experience a noticeable change in how often they need to go to the bathroom, whether that means new constipation (difficulty passing stool) or diarrhea (loose, watery stools).^[7]

You might also feel pain in your abdomen that doesn’t go away, or notice unexplained weight loss even though you haven’t changed your diet or exercise routine. Some people feel constantly tired or weak without a clear reason. These symptoms don’t automatically mean you have rectal cancer, as many other conditions can cause similar problems, but they are signals that your body is trying to tell you something needs attention.^[3]

If you have certain risk factors, you should be especially alert to these warning signs. People with a first-degree relative—meaning a parent, sibling, or child—who has had colon or rectal cancer face higher risk. Those who have had colon, rectal, or ovarian cancer themselves in the past need to watch carefully. Certain inherited genetic conditions, a personal history of inflammatory bowel diseases like Crohn’s disease or ulcerative colitis, and lifestyle factors like smoking or heavy alcohol consumption also increase your chances of developing rectal cancer.^[3]

The average age at diagnosis is 63, meaning rectal cancer occurs more commonly in older adults, though it can develop at any age. Regular screening becomes especially important as you get older, since the risk increases with age.^[7]

⚠️ Important

Many people live with rectal cancer for years without noticing any changes in their body. In many cases, rectal cancers don’t cause symptoms at all during the early stages. This is why regular screening tests matter so much—they can catch cancer before symptoms appear, when treatment is often more straightforward.

Classic Diagnostic Methods

When you visit your doctor with concerns about possible rectal cancer, the diagnostic journey typically begins with a physical examination. Your healthcare provider will likely perform a digital rectal examination (DRE), which involves inserting a gloved, lubricated finger into your rectum to feel for any unusual lumps or areas that don’t feel normal. While this test might feel uncomfortable, it provides valuable initial information about what might be happening inside your body.^[7]

The next step usually involves a colonoscopy, which allows doctors to look inside your entire large intestine, including your rectum. During this procedure, you’ll receive medication to help you relax or sleep. Your doctor then guides a long, flexible tube with a tiny camera on the end through your anus and up into your colon. This camera sends images to a screen, letting your doctor examine the lining of your intestine carefully. If they spot anything suspicious—such as a polyp (an abnormal growth)—they can remove it or take a sample during the same procedure.^[7]

A sigmoidoscopy works similarly to a colonoscopy but examines only the lower portion of your colon and rectum rather than the entire large intestine. Your doctor might recommend this test if they suspect the problem is located in the lower areas of your digestive tract.

When doctors find something that looks abnormal during these examinations, they perform a biopsy. This means taking a small piece of tissue from the suspicious area and sending it to a laboratory. There, a specialist called a pathologist examines the cells under a microscope to determine whether they are cancerous. The biopsy provides the definitive answer about whether you have cancer.^[7]

Blood tests play an important supporting role in diagnosis. Your doctor might order a complete blood count to check for anemia (low red blood cell levels), which can occur when rectal tumors bleed slowly over time. Another common blood test measures carcinoembryonic antigen (CEA), a protein that can be elevated in people with colorectal cancer. However, these blood tests alone cannot diagnose cancer—they provide clues that help guide your healthcare team.^[7]

Once cancer is confirmed through biopsy, additional tests determine how far the disease has spread. This process is called staging, and it’s crucial for planning your treatment. For stage III rectal cancer specifically, doctors need to know that the cancer has grown through the rectal wall and spread to nearby lymph nodes (small bean-shaped organs that are part of your immune system), but has not reached distant parts of your body.^[2]

To gather this staging information, your medical team will order imaging tests. These create detailed pictures of the inside of your body without requiring surgery. A computed tomography (CT) scan uses X-rays and computer technology to produce cross-sectional images of your abdomen, pelvis, and chest. During the scan, you lie still on a table that slides through a large, donut-shaped machine. The entire process usually takes about 30 minutes, and it’s painless.^[5]

Another valuable imaging tool is magnetic resonance imaging (MRI), which uses powerful magnets and radio waves instead of X-rays to create detailed images. MRI is particularly good at showing soft tissues, making it especially useful for examining the rectum and surrounding structures. Like a CT scan, you lie on a table that slides into a tube-shaped machine. The test takes longer than a CT scan, sometimes up to an hour, and the machine makes loud thumping and buzzing noises, though you’ll receive earplugs or headphones.^[5]

Your doctor might also recommend a pelvic ultrasound or a specialized version called transrectal ultrasound. This test uses sound waves to create images. For a transrectal ultrasound, a small probe is inserted into your rectum. The sound waves bounce off tissues and create pictures that help doctors see how deeply the tumor has grown into the rectal wall.

Sometimes imaging tests provide all the information needed for staging, but in certain situations, your healthcare team might need to perform surgery to accurately determine the stage. This happens when imaging results are unclear or when more definitive information is necessary to make treatment decisions.^[5]

Understanding Stage III Rectal Cancer Categories

Stage III rectal cancer is divided into three subcategories—IIIA, IIIB, and IIIC—based on how far the cancer has spread into the layers of the rectal wall and how many lymph nodes contain cancer cells. These distinctions help your healthcare team predict how the disease might behave and tailor treatment accordingly.^[2]

In stage IIIA, the cancer has either spread through the inner layers of the rectum to the muscle layer and reached one to three nearby lymph nodes, or it has remained in the innermost layers but spread to four to six lymph nodes. Think of it as cancer that’s starting to move beyond its original location but hasn’t traveled very far yet.^[2]

Stage IIIB means the cancer has grown through more layers of the rectal wall—possibly reaching the outermost layer or even the tissue covering nearby organs—and has spread to one to three lymph nodes. Alternatively, it might have reached the muscle or outer layer of the rectal wall and spread to four to six lymph nodes, or stayed in the inner layers but reached seven or more lymph nodes.^[6]

The most advanced subcategory, stage IIIC, involves cancer that has grown through the outer lining into the tissue covering abdominal organs and spread to four to six lymph nodes, or cancer that has reached seven or more lymph nodes, or cancer that has grown completely through the rectal wall into nearby organs with at least one affected lymph node.^[6]

Doctors use a system called TNM staging to describe these categories more precisely. The “T” refers to the size and extent of the main tumor, “N” indicates whether and how many lymph nodes contain cancer, and “M” shows whether the cancer has spread to distant parts of the body. In all stage III rectal cancers, the M is 0, meaning the cancer has not spread to distant organs like the liver or lungs.^[5]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new ways to treat cancer. If you’re interested in participating in a clinical trial for stage III rectal cancer, you’ll need to undergo specific diagnostic tests to determine whether you qualify. These tests ensure that researchers can accurately evaluate how well the experimental treatment works and keep participants safe.^[11]

Before enrolling in any clinical trial, you’ll need comprehensive staging tests to confirm you have stage III disease. This typically includes the same CT scans, MRI scans, or ultrasound examinations used for standard diagnosis. Researchers need to document exactly where the cancer is located, how large it is, and how many lymph nodes are involved at the start of the study. This baseline information allows them to measure whether the treatment causes the tumor to shrink or prevents it from growing.^[11]

Many clinical trials require specific blood tests before you can participate. These might include tests of your liver function and kidney function to ensure these organs can handle the treatment being studied. Complete blood counts check that you have enough healthy blood cells to tolerate chemotherapy or other treatments. Some trials also measure CEA levels before treatment begins, then check them again during and after treatment to see if they decrease.^[11]

Certain trials investigate treatments that target specific genetic changes in cancer cells. For these studies, you’ll need molecular testing or biomarker testing of your tumor tissue. Laboratory scientists examine the cancer cells from your biopsy looking for particular genetic mutations or protein markers. Only patients whose tumors have the specific characteristics being targeted by the experimental treatment can join these trials.

The importance of knowing your tumor’s biomarker status extends beyond clinical trials—it informs which treatments are most likely to work for your specific cancer. Different biomarkers can affect how your cancer responds to various therapies, making this information valuable for all treatment decisions, not just for research studies.

⚠️ Important

Pre-treatment staging is critically important because the timing and sequence of your therapies can significantly impact your outcome. For stage III rectal cancer, many patients receive chemotherapy and radiation before surgery, which can shrink the tumor and make it easier to remove completely. Accurate diagnostic information helps your healthcare team plan the best sequence of treatments for your specific situation.

Clinical trials might also require functional tests to ensure you’re healthy enough to participate. A physical examination checks your overall health status. Some studies require heart function tests, such as an electrocardiogram (ECG), which measures the electrical activity of your heart, or an echocardiogram, which uses sound waves to create moving pictures of your heart. These tests make sure your heart can safely handle the treatments being studied.

Depending on the specific trial, you might need additional diagnostic procedures. Some studies require a repeat colonoscopy or sigmoidoscopy before treatment starts. Others might ask for specialized imaging tests beyond the standard CT or MRI scans.

Throughout your participation in a clinical trial, you’ll undergo regular follow-up testing. These tests track how your cancer responds to treatment and watch for any side effects. The schedule of these tests is carefully planned as part of the research protocol and is typically more frequent than follow-up testing for standard treatment.

If you’re considering a clinical trial, discuss with your healthcare team which trials might be appropriate for your situation and what diagnostic tests each trial requires. Understanding these requirements upfront helps you make an informed decision about participation.

Prognosis and Survival Rate

Prognosis

The outlook for people with stage III rectal cancer depends on several factors that influence how the disease might progress. The most important factor is the stage itself—specifically, which subcategory (IIIA, IIIB, or IIIC) applies to your situation. Generally, earlier subcategories within stage III have better outcomes than more advanced ones. The number of lymph nodes containing cancer cells plays a significant role, as does how deeply the tumor has grown into the rectal wall or surrounding tissues. People whose tumors have spread to only one to three lymph nodes typically have better prognoses than those with cancer in seven or more lymph nodes.^[2]^[6]

Your overall health and age at diagnosis also matter. Younger patients and those without other serious medical conditions often respond better to treatment and have better long-term outcomes. Certain factors in your medical history, such as whether you have chronic inflammatory bowel disease or inherited genetic conditions, can influence your prognosis as well.^[3]

The treatment you receive significantly affects your prognosis. Stage III rectal cancer is typically treated with a combination of approaches. In the United States, the standard approach involves radiation therapy and chemotherapy before surgery to shrink the tumor, followed by surgical removal of the cancer, and then additional chemotherapy afterward. This comprehensive treatment strategy, called total neoadjuvant therapy, has been shown to improve outcomes by decreasing the chance of the cancer returning locally and potentially improving survival.^[11]^[16]

Surgery plays a crucial role in achieving the best possible outcome. The goal is to remove all visible cancer along with surrounding healthy tissue and affected lymph nodes. When surgeons can completely remove the tumor with clear margins—meaning no cancer cells are found at the edges of the removed tissue—the prognosis is generally more favorable.

For some patients whose tumors respond exceptionally well to pre-surgery treatment, healthcare teams might discuss a “watch-and-wait” approach instead of immediate surgery. This strategy involves careful monitoring with regular examinations and imaging tests. It’s only considered when the tumor appears to have completely disappeared after chemotherapy and radiation, and it requires very close follow-up to ensure the cancer hasn’t returned.^[21]

Survival Rate

Survival rates help you understand what percentage of people with your stage of cancer are still alive a certain number of years after diagnosis. It’s important to remember that these are statistics based on large groups of people, and your individual experience may be quite different. Many factors—including advances in treatment that occurred after these statistics were collected—can affect your personal outcome.^[7]

For stage III rectal cancer, which is considered regional disease because it has spread to nearby lymph nodes but not to distant organs, the 5-year survival rate ranges from approximately 72% to 74%. This means that about 72 to 74 out of every 100 people diagnosed with stage III rectal cancer are still alive five years after their diagnosis.^[18]

The survival rate for stage III disease falls between that of earlier and later stages. Localized rectal cancer, which hasn’t spread beyond the rectum itself (stages 0, I, and II), has a 5-year survival rate of 90% to 91%. In contrast, distant or metastatic rectal cancer, which has spread to organs like the liver or lungs (stage IV), has a 5-year survival rate of 13% to 17%.^[18]

These numbers reflect averages and estimates based on data collected from many patients over several years. They don’t account for individual variations in tumor biology, treatment response, or personal health factors. Moreover, treatments for rectal cancer continue to improve, meaning people diagnosed today may have better outcomes than these historical statistics suggest.

Your healthcare team can provide more personalized information about your prognosis based on the specific characteristics of your cancer, your overall health, and your treatment plan. They understand that while statistics provide useful context, each person’s journey with cancer is unique.

#1 Clinical Trials Search in Europe